Exogenous antigens are processed through the endoplasmic reticulum-associated degradation (ERAD) in cross-presentation by dendritic cells

International Immunology

Volumn 17, Issue 1, 2005, Pages 45-53

  Imai, Jun ^a,b   Hasegawa, Hironori ^a,c   Maruya, Mikako ^a,b   Koyasu, Shigeo ^a,b   Yahara, Ichiro ^a,b,c  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c Medical & Biological Laboratories Co Ltd   (Japan)

Author keywords

CHIP; Ovalbumin; RNAi; Sec61; VCP

Indexed keywords

ANTIGEN; HEAT SHOCK COGNATE PROTEIN 70; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MEMBRANE PROTEIN; OVALBUMIN; PROTEASOME; SECRETORY PROTEIN; UBIQUITIN PROTEIN LIGASE E3;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL LINE; CELL TRANSPORT; CONTROLLED STUDY; CROSS PRESENTATION; CYTOPLASM; DENDRITIC CELL; ENDOPLASMIC RETICULUM; ENDOSOME; MOLECULAR MECHANICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; QUALITY CONTROL;

ANIMALS; CARRIER PROTEINS; CELL LINE; CELL MEMBRANE; CROSS-PRIMING; DENDRITIC CELLS; ENDOPLASMIC RETICULUM; HISTOCOMPATIBILITY ANTIGENS CLASS I; MICE; MICE, TRANSGENIC; OVALBUMIN; PROTEASOME ENDOPEPTIDASE COMPLEX; RNA INTERFERENCE; UBIQUITIN-PROTEIN LIGASES;

EID: 12444339508     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/dxh184     Document Type: Article

References (39)

1. Janeway, C., Travers, P., Walport, M. and Shlomchik, M. 2001. Immunobiology: The Immune system in Health and Disease 5th edn. Garland Press, New York, NY.
2. Yewdell, J., Anton, L. C., Bacik, I., Schubert, U., Snyder, H. L. and Bennink, J. R. 1999. Generating MHC class I ligands from viral gene products. Immunol. Rev. 172:97.
3. Huang, A. Y., Golumbek, P., Ahmadzadeh, M., Jaffee, E., Pardoll, D. and Levitsky, H. 1994. Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens. Science 264:961.
4. Banchereau, J. and Steinman, R. M. 1998. Dendritic cells and the control of immunity. Nature 392:245.
5. Steinman, R. M. 1991. The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol. 9:271.
6. Guermonprez, P., Valladeau, J., Zitvogel, L., Thery, C. and Amigorena, S. 2002. Antigen presentation and T cell stimulation by dendritic cells. Annu. Rev. Immunol. 20:621.
7. Bevan, M. J. 1976. Minor H antigens introduced on H-2 different stimulating cells cross-react at the cytotoxic T cell level during in vivo priming. J. Immunol. 117:2233.
8. Rock, K. L., Gamble, S. and Rothstein, L. 1990. Presentation of exogenous antigen with class I major histocompatibility complex molecules. Science 249:918.
9. Melief, C. J. M. 2003. Regulation of cytotoxic T lymphocyte responses by dendritic cells: peaceful coexistence of cross-priming and direct priming? Eur. J. Immunol. 33:2645.
10. Heath, W. R. and Carbone, F. R. 2001. Cross-presentation, dendritic cells, tolerance and immunity. Annu. Rev. Immunol. 20:47.
11. Heath, W. R. and Carbone, F. R. 2001. Cross-presentation in viral immunity and self-tolerance. Nat. Rev. Immunol. 1:126.
12. Rodriguez, A., Regnault, A., Kleijmeer, M., Ricciardi-Castagnoli, P. and Amigorena, S. 1999. Selective transport of internalized antigens to the cytosol for MHC class I presentation in dendritic cells. Nat. Cell Biol. 1:362.
13. Kloetzel, P. M. 2001. Antigen processing by the proteasome. Nat. Rev. Mol. Cell Biol. 2:179.
14. Huang, A. Y., Bruce, A. T., Pardoll, D. M. and Levitsky, H. I. 1996. In vivo cross-priming of MHC class I-restricted antigens requires the TAP transporter. Immunity 4:349.
15. Guermonprez, P., Saveanu, L., Kleijmeer, M., Davoust, J., Van Endert, P. and Amigorena, S. 2003. ER-phagosome fusion defines an MHC class I cross-presentation compartment in dendritic cells. Nature 425:397.
16. Houde, M. et al. 2003. Phagosomes are competent organelles for antigen cross-presentation. Nature 425:402.
17. Garin, J. et al. 2001. The phagosome proteome: insight into phagosome functions. J. Cell Biol. 152:165.
18. Gagnon, E. et al. 2002. Endoplasmic reticulum-mediated phagocytosis is a mechanism of entry into macrophages. Cell 110:119.
19. Desjardins, M. 2003. ER-mediated phagocytosis: a new membrane for new functions. Nat. Rev. Immunol. 3:280.
20. Lizee, G., Basha, G., Tiong, J., Julien, J. P., Tian, M., Biron, K. E. and Jefferies, W. A. 2003. Control of dendritic cell cross-presentation by the major histocompatibility complex class I cytoplasmic domain. Nat. Immunol. 4:1065.
21. Ackerman, A. L., Kyritsis, C., Tampe, R. and Cresswell, P. 2003. Early phagosomes in dendritic cells form a cellular compartment sufficient for cross presentation of exogenous antigens. Proc. Natl Acad. Sci. USA. 100:12889.
22. Shen, Z., Reznikoff, G., Dranoff, G. and Rock, K. L. 1997. Cloned dendritic cells can present exogenous antigens on both MHC class I and class II molecules. J. Immunol. 158:2723.
23. Wiertz, E. J., Tortorella, D., Bogyo, M., Yu, J., Mothes, W., Jones, T. R., Rapoport, T. A. and Ploegh, H. L. 1996. Sec61-mediated transfer of a membrane protein from the endoplasmic reticulum to the proteasome for destruction. Nature 384:432.
24. Hampton, R. Y. 2002. ER-associated degradation in protein quality control and cellular regulation. Curr. Opin. Cell Biol. 14:476.
25. Tsai, B., Ye, Y. and Rapoport, T. A. 2002. Retro-translocation of proteins from the endoplasmic reticulum into the cytosol. Nat. Rev. Mol. Cell Biol. 3:246.
26. Meacham, G. C., Patterson, C., Zhang, W., Younger, J. M. and Cyr, D. M. 2001. The Hsc70 co-chaperone CHIP targets immature CFFR for proteasomal degradation. Nat. Cell Biol. 3:100.
27. 2+ required for glycosylation, sorting and endoplasmic reticulum-associated protein degradation. Mol. Biol. Cell 9:1149.
28. 2+] in the endoplasmic reticulum and cytoplasm of intact HeLa cells. A comparative study. J. Biol. Chem. 272:27694.
29. Treiman, M., Caspersen, C. and Christensen, S. B. 1998. A tool coming of age: thapsigargin as an inhibitor of sarco-endoplasmic reticulum Ca(2+)-ATPases. Trends Pharmacol. Sci. 19:131.
30. Duksin, D. and Mahoney, W. C. 1982. Relationship of the structure and biological activity of the natural homologues of tunicamycin. J. Biol. Chem. 257:3105.
31. Schild, H. and Rammensee, H. G. 2000. Perfect use of imperfection. Nature 404:709.
32. Sherman, M. Y. and Goldberg, A. L. 2001. Cellular defenses against unfolded proteins: a cell biologist thinks about neurodegenerative diseases. Neuron 29:15.
33. Schirmbeck, R., Bohm, W. and Reimann, J. 1997. Stress protein (hsp73)-mediated, TAP-independent processing of endogenous, truncated SV40 large T antigen for Db-restricted peptide presentation. Eur. J. Immunol. 27:2016.
34. Plemper, R. K. and Wolf, D. H. 1999. Retrograde protein translocation: ERADication of secretory proteins in health and disease. Trends Biochem. Sci. 24:266.
35. Minshall, R. D., Tiruppathi, C., Vogel, S. M., Niles, W. D., Gilchrist, A., Hamm, H. E. and Malik, A. B. 2000. Endothelial cell-surface gp60 activates vesicle formation and trafficking via G(i)-coupled Src kinase signaling pathway. J. Cell Biol. 150:1057.
36. Schubert, U., Anton, L. C., Gibbs, J., Norbury, C. C., Yewdell, J. W. and Bennink, J. R. 2000. Rapid degradation of a large fraction of newly synthesized proteins by proteasomes. Nature 404:770.
37. Reits, E. A., Vos, J. C., Gromme, M. and Neefjes. J. 2000. The major substrates for TA-P in vivo are derived from newly synthesized proteins. Nature 404:774.
38. Lelouard, H., Gatti, E., Cappello, F., Gresser, O., Camossetto, V. and Pierre, P. 2002. Transient aggregation of ubiquitinated proteins during dendritic cell maturation. Nature 417:177.
39. Lelouard, H., Ferrand, V., Marguet, D., Bania, J., Camosseto, V., David, A., Gatti, E. and Pierre, P. 2004. Dendritic cell aggresome-like induced structures are dedicated areas for ubiquitination and storage of newly synthesized defective proteins. J. Cell Biol. 164:667.